Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study

Hypertension. 2020 Aug;76(2):e10-e12. doi: 10.1161/HYPERTENSIONAHA.120.15312. Epub 2020 May 8.

Andrea Conversano^#¹, Francesco Melillo^#¹, Antonio Napolano¹, Evgeny Fominskiy², Marzia Spessot³, Fabio Ciceri^{4

5}, Eustachio Agricola^{1

5}

¹ From the Cardiovascular Imaging Unit, Cardiothoracic Department (C.A., M.F., N.A., A.E.), San Raffaele Hospital, IRCCS, Milan, Italy.
² Anesthesia and Intensive Care Department (F.E.), San Raffaele Hospital, IRCCS, Milan, Italy.
³ Emergency Department (S.M.), San Raffaele Hospital, IRCCS, Milan, Italy.
⁴ Hematology and Bone Marrow Transplantation Unit (C.F.), San Raffaele Hospital, IRCCS, Milan, Italy.
⁵ Vita-Salute San Raffaele University, Milan, Italy (C.F., A.E.).

^# Contributed equally.

No abstract available

Keywords: COVID-19; SARS virus; angiotensin receptor antagonists; longitudinal studies; renin-angiotensin system.

Publication types